Earnings Summary

Minerva Neurosciences, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Minerva Neurosciences, Inc. has generated NaN% jump in its revenue since last 3-months.

Minerva Neurosciences, Inc.’s net profit fell -7.64% since last year same period to $-9.02Mn in the Q4 2023. On a quarterly growth basis, Minerva Neurosciences, Inc. has generated -15.37% fall in its net profits since last 3-months.

Minerva Neurosciences, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Minerva Neurosciences, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Minerva Neurosciences, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.2 - a -36.36% fall from last quarter’s estimates.

Minerva Neurosciences, Inc.’s earning per share (EPS) estimates for the current year stand at -1.2.

Minerva Neurosciences, Inc.’s earning per share (EPS) fell -10.32% since last year same period to -1.39 in the Q4 2023. This indicates that the Minerva Neurosciences, Inc. has generated -10.32% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Minerva Neurosciences, Inc.’s return on assets (ROA) stands at -0.26.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Minerva Neurosciences, Inc.’s return on equity (ROE) stands at -6.75.